Deal

CapMan Life Science IV invests in Hermelinen

CapMan Life Science IV fund has invested in Hermelinen, a Swedish private health care centre.

Hermelinen, founded in 1990, is a private health care centre that provides specialist and occupational care in Northern Sweden.

 

The investment will help support the company´s growth strategy.

 

The transaction is subject to approval by relevant competition authorities and is expected to be finalised by the end of February, 2010.

 

Read more


FundCapMan Life Science IV
Portfolio CompanyHermelinen
Date of Transaction2010-02-09
TransactionAcquisition
Seller
Buyer
Size of Transaction 
Ind. FocusLife Science
GeographySweden
StageSmall/mid-cap buyout
 

More deals

(2011-07-13)